{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:56:23Z","timestamp":1789192583261,"version":"build-2803163510"},"reference-count":147,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.2217\/imt.14.65","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T10:40:30Z","timestamp":1417084830000},"page":"1127-1143","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":42,"title":["Anti-TNF Therapeutics for the Treatment of Sarcoidosis"],"prefix":"10.1080","volume":"6","author":[{"given":"Heleen A","family":"Crommelin","sequence":"first","affiliation":[{"name":"Centre of Interstitial Lung Diseases,Department Of Pulmonology,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"},{"name":"Department of Clinical Pharmacy,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane DM","family":"Vorselaars","sequence":"additional","affiliation":[{"name":"Centre of Interstitial Lung Diseases,Department Of Pulmonology,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coline HM","family":"van Moorsel","sequence":"additional","affiliation":[{"name":"Centre of Interstitial Lung Diseases,Department Of Pulmonology,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"},{"name":"Division of Heart &amp; Lungs,University Medical Centre Utrecht,\rUtrecht,\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid HE","family":"Korenromp","sequence":"additional","affiliation":[{"name":"Centre of Interstitial Lung Diseases,Department Of Pulmonology,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera HM","family":"Deneer","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C","family":"Grutters","sequence":"additional","affiliation":[{"name":"Centre of Interstitial Lung Diseases,Department Of Pulmonology,St Antonius Hospital,\rNieuwegein,\rThe Netherlands"},{"name":"Division of Heart &amp; Lungs,University Medical Centre Utrecht,\rUtrecht,\rThe Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2012.01198.x"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201006-0865CI"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2013.02.007"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283645950"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.035"},{"key":"e_1_3_2_12_1","article-title":"Sarcoidosis","author":"Valeyre D","year":"2013","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet (2013).","journal-title":"Lancet"},{"issue":"1","key":"e_1_3_2_13_1","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal G","year":"1984","unstructured":"Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am. Rev. Respir. Dis. 130(1), 29\u201332 (1984).","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00075307"},{"issue":"2","key":"e_1_3_2_15_1","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson MA","year":"2012","unstructured":"Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc. Diffuse Lung Dis. 29(2), 119\u2013127 (2012).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.406"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283043de7"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0413"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009096"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1976.tb47043.x"},{"issue":"2","key":"e_1_3_2_21_1","first-page":"159","article-title":"The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients","volume":"13","author":"Pietinalho A","year":"1996","unstructured":"Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc. Diffuse Lung Dis. 13(2), 159\u2013166 (1996).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)89518-6"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1679OC"},{"issue":"7","key":"e_1_3_2_24_1","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai K","year":"1993","unstructured":"Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol. Jpn 43(7\u20138), 372\u2013376 (1993).","journal-title":"Acta Pathol. Jpn"},{"issue":"1","key":"e_1_3_2_25_1","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai K","year":"1994","unstructured":"Iwai K, Sekiguti M, Hosoda Y et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11(1), 26\u201331 (1994).","journal-title":"Sarcoidosis"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90160-0"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01365.x"},{"issue":"1","key":"e_1_3_2_28_1","first-page":"36","article-title":"Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis","volume":"115","author":"Baughman RP","year":"1990","unstructured":"Baughman RP, Strohofer SA, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J. Lab. Clin. Med. 115(1), 36\u201342 (1990).","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00103302"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.1.251"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1262208"},{"issue":"437","key":"e_1_3_2_32_1","article-title":"Granuloma formation in pulmonary sarcoidosis","volume":"4","author":"Broos CE","year":"2013","unstructured":"Broos CE, van Nimwegen M, Hoogsteden HC, Hendriks RW, Kool M, van den Blink B. Granuloma formation in pulmonary sarcoidosis. Front. Immunol. 4, 437 (2013).","journal-title":"Front. Immunol."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.10"},{"key":"e_1_3_2_34_1","first-page":"405","article-title":"Emerging trends in the formation and function of tuberculosis granulomas","volume":"3","author":"Lugo-Villarino G","year":"2012","unstructured":"Lugo-Villarino G, Hudrisier D, Benard A, Neyrolles O. Emerging trends in the formation and function of tuberculosis granulomas. Front. Immunol. 3, 405 (2012).","journal-title":"Front. Immunol."},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.suppl_2.ii54"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.09.011"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-970330"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.11.2106001"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201209-1582ED"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.03.018"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000052"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.08.010"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00105805"},{"issue":"2","key":"e_1_3_2_44_1","first-page":"CD001114","article-title":"Corticosteroids for pulmonary sarcoidosis","volume":"2","author":"Paramothayan NS","year":"2005","unstructured":"Paramothayan NS, Lasserson TJ, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst. Rev. (2)(2), CD001114 (2005).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.1.24"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.2174\/18715281113126660062"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1728"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri802"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.10.001"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342607"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(89)90040-8"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.15.8093"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4620"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.5.97-02050"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2013.05.006"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-699X.2010.00214.x"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-013-2859-x"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2009.01437.x"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.8.200110-0320"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-007-0185-7"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00169413"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200303-459OC"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.1.227"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.07.006"},{"issue":"1","key":"e_1_3_2_65_1","first-page":"51","article-title":"The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis","volume":"23","author":"Judson MA","year":"2006","unstructured":"Judson MA, Silvestri J, Hartung C, Byars T, Cox CE. The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 23(1), 51\u201357 (2006).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2012.03.005"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.5.9154873"},{"issue":"2","key":"e_1_3_2_68_1","first-page":"121","article-title":"Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis","volume":"26","author":"Park MK","year":"2009","unstructured":"Park MK, Fontana J, Babaali H et al. Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 26(2), 121\u2013131 (2009).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.301"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.177"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0012-3692(15)50471-6"},{"issue":"3","key":"e_1_3_2_72_1","first-page":"201","article-title":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis","volume":"23","author":"Rossman MD","year":"2006","unstructured":"Rossman MD, Newman LS, Baughman RP et al. A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 23(3), 201\u2013208 (2006).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-402OC"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2013.797891"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00051907"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1159\/000328738"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.10.008"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.056"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1844-0"},{"issue":"1","key":"e_1_3_2_80_1","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss NJ","year":"2014","unstructured":"Sweiss NJ, Noth I, Mirsaeidi M et al. Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 31(1), 46\u201354 (2014).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(97)90134-7"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00131505"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2008.03.012"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.2.9804085"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.4.1526"},{"issue":"4","key":"e_1_3_2_86_1","first-page":"719","article-title":"Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP","volume":"64","author":"Katakami Y","year":"1988","unstructured":"Katakami Y, Nakao Y, Koizumi T, Katakami N, Ogawa R, Fujita T. Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP. Immunology 64(4), 719\u2013724 (1988).","journal-title":"Immunology"},{"key":"e_1_3_2_87_1","unstructured":"Remicade\u00ae (infliximab) prescribing information. Centocor Inc. PA USA (2006)."},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.11.019"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3180318fbc"},{"issue":"8","key":"e_1_3_2_90_1","first-page":"1686","article-title":"Successful treatment of cardiac sarcoidosis with infliximab","volume":"35","author":"Barnabe C","year":"2008","unstructured":"Barnabe C, McMeekin J, Howarth A, Martin L. Successful treatment of cardiac sarcoidosis with infliximab. J. Rheumatol. 35(8), 1686\u20131687 (2008).","journal-title":"J. Rheumatol."},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.149989"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02457.x"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e3181dc9a54"},{"key":"e_1_3_2_94_1","unstructured":"Humira\u00ae (adalimumab) prescribing information. Abbott Laboratories IL USA (2007)."},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-699X.2011.00276.x"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.4076\/1752-1947-3-8573"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2007.0104"},{"key":"e_1_3_2_98_1","unstructured":"Enbrel\u00ae (etanercept) precribing information. Immunex Corp. CA USA (2007)."},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901283400401"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.28674"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.67"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq031"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.01.005"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.12.009"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3030"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(00)89088-1"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-9255-9-38"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.301.2.418"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.060"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02309.x"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00382-2"},{"issue":"7","key":"e_1_3_2_113_1","first-page":"1","article-title":"Highlights in anti-tumor necrosis factor monitoring","volume":"8","author":"Sandborn WJ.","year":"2012","unstructured":"Sandborn WJ. Highlights in anti-tumor necrosis factor monitoring. Gastroenterol. Hepatol. 8(7 Suppl. 4), 1\u201312 (2012).","journal-title":"Gastroenterol. Hepatol."},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsymp.5650032"},{"key":"e_1_3_2_115_1","first-page":"13","article-title":"Clinical pharmacokinetics of tumor necrosis factor antagonists","volume":"74","author":"Nestorov I.","year":"2005","unstructured":"Nestorov I. Clinical pharmacokinetics of tumor necrosis factor antagonists. J. Rheumatol. Suppl. 74, 13\u201318 (2005).","journal-title":"J. Rheumatol. Suppl."},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.01.004"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1159\/000354703"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.07.006"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.1064"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.004226"},{"key":"e_1_3_2_122_1","first-page":"308092","article-title":"Bilateral vocal cord carcinoma in a sarcoidosis patient during Infliximab therapy","volume":"2013","author":"Vorselaars AD","year":"2013","unstructured":"Vorselaars AD, Sjogren EV, van Moorsel CH, Grutters JC. Bilateral vocal cord carcinoma in a sarcoidosis patient during Infliximab therapy. Case Rep. Pulmonol. 2013, 308092 (2013).","journal-title":"Case Rep. Pulmonol."},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140102"},{"issue":"2","key":"e_1_3_2_124_1","first-page":"95","article-title":"Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection","volume":"28","author":"Gupta D","year":"2011","unstructured":"Gupta D, Kumar S, Aggarwal AN, Verma I, Agarwal R. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Sarcoidosis Vasc. Diffuse Lung Dis. 28(2), 95\u2013101 (2011).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04682.x"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020888"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50145"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.170"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008316886"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200405000-00008"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.11.024"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201544"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02612.x"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep046"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.3.623"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2009.01518.x"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055213"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2629"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1373\/49.9.1510"},{"issue":"2","key":"e_1_3_2_142_1","first-page":"143","article-title":"18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab","volume":"25","author":"Keijsers RG","year":"2008","unstructured":"Keijsers RG, Verzijlbergen JF, van Diepen DM, van den Bosch JM, Grutters JC. 18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc. Diffuse Lung Dis. 25(2), 143\u2013149 (2008).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00088612"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328363ed0d"},{"issue":"1","key":"e_1_3_2_145_1","first-page":"66","article-title":"Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET","volume":"55","author":"Keijsers RG","year":"2011","unstructured":"Keijsers RG, Grutters JC, Thomeer M et al. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. Q. J. Nucl. Med. Mol. Imaging 55(1), 66\u201371 (2011).","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.02.026"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11168"},{"issue":"2","key":"e_1_3_2_148_1","first-page":"127","article-title":"The relationship between fatigue and clinical parameters in pulmonary sarcoidosis","volume":"21","author":"De Vries J","year":"2004","unstructured":"De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M. The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 21(2), 127\u2013136 (2004).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"2","key":"e_1_3_2_149_1","first-page":"90","article-title":"Endpoints for clinical trials of sarcoidosis","volume":"29","author":"Baughman RP","year":"2012","unstructured":"Baughman RP, Drent M, Culver DA et al. Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 29(2), 90\u201398 (2012).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.14.65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T12:33:17Z","timestamp":1715949197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.14.65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":147,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.2217\/imt.14.65"],"URL":"https:\/\/doi.org\/10.2217\/imt.14.65","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-11-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}